Shell PLC (SHEL) Stock Price Today
Aura AI Summary
Key Stats
- $307.26BMarket Cap
- 4,656,592Volume
- EnergySector
- $108.1852W High
- $70.3152W Low
- 91 DaysTypical Hold Time
- $348.96BEnterprise Value
- 2.89%Div Yield
- -Trading Activity
Track Shell PLC (SHEL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Shell PLC has traded between a low of $70.31 and a high of $108.18, highlighting its annual price range. Buy and sell Shell PLC shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Most Recent News
62% of Americans plan to buy secondhand gifts this holiday, valuing uniqueness over new items
ThredUp's 2026 Holiday Resale Report reveals that 62% of Americans intend to buy secondhand gifts this holiday season, with 55% preferring unique, vintage items over brand-new ones. Shoppers are allocating about 37% of their gift budget to secondhand...

Neo Security appoints Scott Stout as Chief Revenue Officer to boost agentic software sales.
Neo Security has named Scott Stout as its new Chief Revenue Officer to lead global revenue growth and expand sales of its agentic software security platform. Stout brings over 20 years of cybersecurity experience, including leadership roles at Cisco ...

Senseonics starts first human trial of Freedom, a transmitter-free CGM system aiming for 2028 launch
Senseonics Holdings has begun the first human clinical trial of Freedom, a next-generation continuous glucose monitoring (CGM) system designed without an external on-body transmitter. This implantable device communicates directly with mobile devices ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.